Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.2975777849699176e-52,39.541210989597225,4687.264049000853,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL9', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS6', 'RPL22', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL13', 'RPS2', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",9.365120909314565e-50,0,0,60
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,4.297254775617653e-26,17.837565104166668,1041.8785502502542,"['NDUFB9', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFB10', 'NDUFA12', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'SLC25A5']",6.1021017813770675e-24,0,0,37
3,Nonalcoholic fatty liver disease WP4396,1.443966622674252e-15,7.872473821116521,269.01331392012685,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'BAX']",1.3669550694649586e-13,0,0,32
4,Mitochondrial complex I assembly model OXPHOS system WP4324,2.5493080391974068e-12,13.96798493408663,372.87813955025393,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'NDUFA6', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB11', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'TMEM126B']",1.8100087078301588e-10,0,0,18
5,Oxidative phosphorylation WP623,3.5242980097315508e-12,12.0795025728988,318.55266751658354,"['NDUFB9', 'ATP5PF', 'NDUFB8', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'ATP5MF', 'ATP5ME']",2.0018012695275207e-10,0,0,19
6,Mitochondrial CIV Assembly WP4922,1.6144199498697375e-09,15.002953980099502,303.7241528644209,"['COX7B', 'COX16', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'COX6B1', 'SCO2', 'COX14']",7.641587762716758e-08,0,0,13
7,Mitochondrial complex III assembly WP4921,6.645471627119429e-05,13.681399631675875,131.60124351485595,"['UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.002696162774431311,0,0,6
8,Type 2 papillary renal cell carcinoma WP4241,0.025648805906671224,4.190261115031757,15.350008648719042,"['SETD2', 'EPAS1', 'COL21A1', 'ELOB']",0.7773794773058741,0,0,4
9,Nanomaterial induced apoptosis WP2507,0.026956102701511126,5.830455259026688,21.068615725327636,"['ENDOG', 'BAX', 'FADD']",0.7773794773058741,0,0,3
10,Ciliary landscape WP4352,0.038255790068504186,1.8873691645797213,6.159354445413514,"['COPS6', 'EXOSC4', 'DNPEP', 'TTC30B', 'NDUFA5', 'XPNPEP3', 'CAMK2A', 'TNKS1BP1', 'COPS7A', 'MYL6B', 'SNRPB2', 'COX6C']",0.7773794773058741,0,0,12
11,Cytosolic DNA-sensing pathway WP4655,0.03974378858635618,2.9619565217391304,9.553203440643399,"['CYLD', 'RNF125', 'TRADD', 'FADD', 'POLR2K']",0.7773794773058741,0,0,5
12,Serotonin and anxiety-related events WP3944,0.041058775209817294,9.05789152955515,28.91958949537866,"['CRH', 'HTR2C']",0.7773794773058741,0,0,2
13,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.041058775209817294,9.05789152955515,28.91958949537866,"['CYP2C8', 'EPHX2']",0.7773794773058741,0,0,2
14,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.041058775209817294,9.05789152955515,28.91958949537866,"['CYP2C8', 'EPHX2']",0.7773794773058741,0,0,2
15,Nanoparticle triggered regulated necrosis WP2513,0.041058775209817294,9.05789152955515,28.91958949537866,"['TRADD', 'FADD']",0.7773794773058741,0,0,2
16,Eukaryotic Transcription Initiation WP405,0.05195314864584514,3.2025903939557474,9.471382317805421,"['TAF13', 'POLR1B', 'POLR2I', 'POLR2K']",0.9221683884637513,0,0,4
17,Cellular Proteostasis WP4918,0.05882470497144165,6.792504570383913,19.244478844824783,"['PFDN4', 'PFDN5']",0.9827186006993782,0,0,2
18,Proteasome Degradation WP183,0.0651663009036642,2.5217864923747277,6.8865268346953705,"['PSMC5', 'H2AFZ', 'PSMC1', 'HLA-B', 'PSMB10']",0.992453573650924,0,0,5
19,Mitochondrial CII Assembly WP4920,0.06876229006578993,inf,inf,['SDHAF1'],0.992453573650924,0,0,1
20,Serotonin and anxiety WP3947,0.07868211633341993,5.43327239488117,13.813222414362176,"['CRH', 'HTR2C']",0.992453573650924,0,0,2
21,DNA Repair Pathways Full Network WP4946,0.0811480638196378,1.9875845633456335,4.991778570248032,"['CENPX', 'POLM', 'TDG', 'APEX1', 'BRCA1', 'GTF2H5', 'RAD54B']",0.992453573650924,0,0,7
22,mRNA Processing WP411,0.08754702326378756,1.9467580390089616,4.741483428595901,"['LSM7', 'SNRPD1', 'SNRPG', 'SNRPE', 'SNRPB2', 'SRSF9', 'LSM2']",0.992453573650924,0,0,7
23,Glycosylation and related congenital defects WP4521,0.09276011580212518,3.1369399830938294,7.4588230270517055,"['DPM2', 'DPM3', 'MAGT1']",0.992453573650924,0,0,3
24,Mitochondrial Gene Expression WP391,0.10026049427436787,4.527117611212676,10.412295976907012,"['CAMK4', 'GABPA']",0.992453573650924,0,0,2
25,CAMKK2  Pathway WP4874,0.10714112088408459,2.912480376766091,6.505340712202184,"['CHRM3', 'FIS1', 'CAMK4']",0.992453573650924,0,0,3
26,Copper homeostasis WP3286,0.10714112088408459,2.912480376766091,6.505340712202184,"['SCO2', 'COX17', 'ATOX1']",0.992453573650924,0,0,3
27,Integrated breast cancer pathway WP1984,0.13165951922689156,1.7329755115732977,3.5136703903320967,"['TRADD', 'DCAKD', 'BAX', 'FADD', 'BRCA1', 'FAU', 'TGFBR2']",0.992453573650924,0,0,7
28,Glucuronidation WP698,0.13280446406585958,13.565693430656934,27.38747225623033,['UGP2'],0.992453573650924,0,0,1
29,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.13280446406585958,13.565693430656934,27.38747225623033,['ELOB'],0.992453573650924,0,0,1
30,Apoptosis Modulation and Signaling WP1772,0.1372484214657128,1.9432773109243697,3.8592762549007533,"['ENDOG', 'IL1R1', 'TRADD', 'BAX', 'FADD']",0.992453573650924,0,0,5
31,Pyrimidine metabolism WP4022,0.14481069314614142,1.7749219312995437,3.429731264129207,"['NT5C', 'POLR1B', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2K']",0.992453573650924,0,0,6
32,Myometrial relaxation and contraction pathways WP289,0.1497057322437523,1.602044144829836,3.0424159169172937,"['IGFBP5', 'RGS16', 'MAFF', 'CAMK2A', 'CRH', 'IGFBP6', 'RYR3', 'GABPA']",0.992453573650924,0,0,8
33,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.17220711077171233,3.0168596384318507,5.306829254129345,"['BAX', 'FADD']",0.992453573650924,0,0,2
34,MECP2 and Associated Rett Syndrome WP3584,0.17457971612987036,1.9415465268676277,3.3887244699458483,"['BCL6', 'SST', 'RPS6', 'CAMK2A']",0.992453573650924,0,0,4
35,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.19244987998931593,6.781934306569343,11.17608194645924,['VIP'],0.992453573650924,0,0,1
36,EV release from cardiac cells and their functional effects WP3297,0.19244987998931593,6.781934306569343,11.17608194645924,['RGS16'],0.992453573650924,0,0,1
37,Gastric acid production WP2596,0.19244987998931593,6.781934306569343,11.17608194645924,['VIP'],0.992453573650924,0,0,1
38,LDLRAD4 and what we know about it WP4904,0.19244987998931593,6.781934306569343,11.17608194645924,['TGFBR2'],0.992453573650924,0,0,1
39,Non-homologous end joining WP438,0.19244987998931593,6.781934306569343,11.17608194645924,['POLM'],0.992453573650924,0,0,1
40,Androgen receptor signaling pathway WP138,0.19457891048201145,1.69921875,2.781480889141913,"['SUMO1', 'KAT5', 'BAG1', 'BRCA1', 'PARK7']",0.992453573650924,0,0,5
41,TP53 network WP1742,0.19772651479440573,2.7148080438756854,4.4003521126340335,"['SUMO1', 'BAX']",0.992453573650924,0,0,2
42,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.20303992381561536,1.8116207951070336,2.8883624158992482,"['CYLD', 'RNF125', 'TRADD', 'FADD']",0.992453573650924,0,0,4
43,VEGFA-VEGFR2 Signaling Pathway WP3888,0.22972277751544998,1.239000171203561,1.8224230649182966,"['RAB4A', 'SET', 'RPS6', 'SARS', 'RPL10A', 'RPL7', 'CYP2C8', 'RPL18A', 'TMSB4X', 'MMRN2', 'GRB10', 'RPLP2', 'RPL27', 'RPL26', 'FADD', 'WASF1', 'CCT7', 'CGNL1']",0.992453573650924,0,0,18
44,DNA IR-double strand breaks and cellular response via ATM WP3959,0.2448375959824463,1.8513986013986015,2.605214355456377,"['KAT5', 'BAX', 'BRCA1']",0.992453573650924,0,0,3
45,Kit receptor signaling pathway WP304,0.2448375959824463,1.8513986013986015,2.605214355456377,"['RPS6', 'GRB10', 'CRKL']",0.992453573650924,0,0,3
46,Serotonin Transporter Activity WP1455,0.24799986477861255,4.520681265206813,6.3033082993782505,['IL1R1'],0.992453573650924,0,0,1
47,Acetylcholine Synthesis WP528,0.24799986477861255,4.520681265206813,6.3033082993782505,['CHKA'],0.992453573650924,0,0,1
48,Sulindac Metabolic Pathway WP2542,0.24799986477861255,4.520681265206813,6.3033082993782505,['MSRB3'],0.992453573650924,0,0,1
49,Codeine and Morphine Metabolism WP1604,0.24799986477861255,4.520681265206813,6.3033082993782505,['CYP2C8'],0.992453573650924,0,0,1
50,Dual hijack model of Vif in HIV infection WP3300,0.24799986477861255,4.520681265206813,6.3033082993782505,['ELOB'],0.992453573650924,0,0,1
51,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.24799986477861255,4.520681265206813,6.3033082993782505,['RYR3'],0.992453573650924,0,0,1
52,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.2498179447351673,2.261730652041438,3.137072089184281,"['BCL6', 'H2AFZ']",0.992453573650924,0,0,2
53,Histone Modifications WP2369,0.2498179447351673,2.261730652041438,3.137072089184281,"['SETD2', 'SET']",0.992453573650924,0,0,2
54,EGF/EGFR signaling pathway WP437,0.2774616031246821,1.3588560885608856,1.742152324930002,"['NDUFA13', 'ATXN2', 'PXDN', 'CAMK2A', 'GRB10', 'NEDD8', 'CRKL']",0.992453573650924,0,0,7
55,22q11.2 copy number variation syndrome WP4657,0.27902600925977245,1.5517693315858454,1.9807563952415839,"['RANBP1', 'MRPL40', 'EMC10', 'CRKL']",0.992453573650924,0,0,4
56,Alzheimer's disease WP2059,0.27902600925977245,1.5517693315858454,1.9807563952415839,"['ATP5MD', 'CHPF2', 'FADD', 'RYR3']",0.992453573650924,0,0,4
57,Tamoxifen metabolism WP691,0.29973514074371455,3.3900547445255476,4.084527997478695,['CYP2C8'],0.992453573650924,0,0,1
58,Cytokines and Inflammatory Response WP530,0.29973514074371455,3.3900547445255476,4.084527997478695,['HLA-DRA'],0.992453573650924,0,0,1
59,Cytosine methylation WP3585,0.29973514074371455,3.3900547445255476,4.084527997478695,['TDG'],0.992453573650924,0,0,1
60,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.29973514074371455,3.3900547445255476,4.084527997478695,['MAFF'],0.992453573650924,0,0,1
61,Kennedy pathway from sphingolipids WP3933,0.29973514074371455,3.3900547445255476,4.084527997478695,['CHKA'],0.992453573650924,0,0,1
62,Leptin and adiponectin WP3934,0.29973514074371455,3.3900547445255476,4.084527997478695,['CPT1A'],0.992453573650924,0,0,1
63,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.29973514074371455,3.3900547445255476,4.084527997478695,['BAX'],0.992453573650924,0,0,1
64,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.29973514074371455,3.3900547445255476,4.084527997478695,['VEGFB'],0.992453573650924,0,0,1
65,miR-509-3p alteration of YAP1/ECM axis WP3967,0.29973514074371455,3.3900547445255476,4.084527997478695,['THBS2'],0.992453573650924,0,0,1
66,Peroxiredoxin 2 induced ovarian failure WP4873,0.29973514074371455,3.3900547445255476,4.084527997478695,['BAX'],0.992453573650924,0,0,1
67,Allograft Rejection WP2328,0.30220552128450734,1.6285714285714286,1.9488266761034705,"['HLA-B', 'HLA-DRA', 'GABPA']",0.992453573650924,0,0,3
68,IL-2 signaling pathway WP49,0.30224456218070517,1.9381039435884042,2.3189777676071373,"['RPS6', 'CRKL']",0.992453573650924,0,0,2
69,IL-18 signaling pathway WP4754,0.32442038451119787,1.2350168350168351,1.3902771260339002,"['KCNH2', 'CPT1A', 'NACA', 'TMSB4X', 'RGS16', 'COX17', 'BAX', 'NDUFC1', 'FADD']",0.992453573650924,0,0,9
70,Pathways in clear cell renal cell carcinoma WP4018,0.3265809998325756,1.4286817962337035,1.598805332497766,"['SETD2', 'TOX2', 'GRB10', 'PFKM']",0.992453573650924,0,0,4
71,Biomarkers for pyrimidine metabolism disorders WP4584,0.3479172233156512,2.7116788321167884,2.8629652693875998,['NT5C'],0.992453573650924,0,0,1
72,Insulin signaling in adipocytes (diabetic condition) WP3635,0.3479172233156512,2.7116788321167884,2.8629652693875998,['RPS6'],0.992453573650924,0,0,1
73,Insulin signaling in adipocytes (normal condition) WP3634,0.3479172233156512,2.7116788321167884,2.8629652693875998,['RPS6'],0.992453573650924,0,0,1
74,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.3479172233156512,2.7116788321167884,2.8629652693875998,['ANXA2'],0.992453573650924,0,0,1
75,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.3479172233156512,2.7116788321167884,2.8629652693875998,['HLA-DRA'],0.992453573650924,0,0,1
76,Pyrimidine metabolism and related diseases WP4225,0.3479172233156512,2.7116788321167884,2.8629652693875998,['NT5C'],0.992453573650924,0,0,1
77,Base Excision Repair WP4752,0.35400031365682666,1.695383912248629,1.7605841048284046,"['TDG', 'APEX1']",0.992453573650924,0,0,2
78,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.35400031365682666,1.695383912248629,1.7605841048284046,"['NDUFA13', 'COPS6']",0.992453573650924,0,0,2
79,Parkinson's disease pathway WP2371,0.35400031365682666,1.695383912248629,1.7605841048284046,"['ATXN2', 'PARK7']",0.992453573650924,0,0,2
80,Integrated Cancer Pathway WP1971,0.3793849124094069,1.5954403699322508,1.5463071711451373,"['BAX', 'BRCA1']",0.992453573650924,0,0,2
81,Oxidation by Cytochrome P450 WP43,0.3793849124094069,1.5954403699322508,1.5463071711451373,"['CYP2C8', 'CYP20A1']",0.992453573650924,0,0,2
82,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.3793849124094069,1.5954403699322508,1.5463071711451373,"['CAMK4', 'CAMK2A']",0.992453573650924,0,0,2
83,Transcriptional cascade regulating adipogenesis WP4211,0.39278973117233107,2.2594282238442824,2.1113923969197925,['DDIT3'],0.992453573650924,0,0,1
84,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.39278973117233107,2.2594282238442824,2.1113923969197925,['RYR3'],0.992453573650924,0,0,1
85,Genes targeted by miRNAs in adipocytes WP1992,0.39278973117233107,2.2594282238442824,2.1113923969197925,['TMSB4X'],0.992453573650924,0,0,1
86,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.39278973117233107,2.2594282238442824,2.1113923969197925,['GABPA'],0.992453573650924,0,0,1
87,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.39278973117233107,2.2594282238442824,2.1113923969197925,['CPT1A'],0.992453573650924,0,0,1
88,White fat cell differentiation WP4149,0.4043396177462754,1.5066016656510257,1.3642279832740036,"['DDIT3', 'NR2F2']",0.992453573650924,0,0,2
89,Monoamine GPCRs WP58,0.4288035274045943,1.4271144039257193,1.2084183164735536,"['CHRM3', 'HTR2C']",0.992453573650924,0,0,2
90,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.4288035274045943,1.4271144039257193,1.2084183164735536,"['TRADD', 'FADD']",0.992453573650924,0,0,2
91,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.4345796084443338,1.9363920750782064,1.6137429386197544,['EPAS1'],0.992453573650924,0,0,1
92,Canonical and non-canonical TGF-B signaling WP3874,0.4345796084443338,1.9363920750782064,1.6137429386197544,['TGFBR2'],0.992453573650924,0,0,1
93,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.4345796084443338,1.9363920750782064,1.6137429386197544,['SYTL3'],0.992453573650924,0,0,1
94,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.4345796084443338,1.9363920750782064,1.6137429386197544,['RPS6'],0.992453573650924,0,0,1
95,Homologous recombination WP186,0.4345796084443338,1.9363920750782064,1.6137429386197544,['RAD54B'],0.992453573650924,0,0,1
96,IL1 and megakaryocytes in obesity WP2865,0.4345796084443338,1.9363920750782064,1.6137429386197544,['IL1R1'],0.992453573650924,0,0,1
97,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.4345796084443338,1.9363920750782064,1.6137429386197544,['TGFBR2'],0.992453573650924,0,0,1
98,MTHFR deficiency WP4288,0.4345796084443338,1.9363920750782064,1.6137429386197544,['CHKA'],0.992453573650924,0,0,1
99,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.4345796084443338,1.9363920750782064,1.6137429386197544,['HLA-DRA'],0.992453573650924,0,0,1
100,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4345796084443338,1.9363920750782064,1.6137429386197544,['ANAPC11'],0.992453573650924,0,0,1
101,"GPCRs, Class A Rhodopsin-like WP455",0.4381990532917885,1.169022565922921,0.9645394910817414,"['CHRM3', 'GPR22', 'NPY1R', 'HTR2C', 'OR6A2']",0.992453573650924,0,0,5
102,Common Pathways Underlying Drug Addiction WP2636,0.4527261154463574,1.3555758683729433,1.0742504132229944,"['CAMK4', 'CAMK2A']",0.992453573650924,0,0,2
103,Energy Metabolism WP1541,0.4527261154463574,1.3555758683729433,1.0742504132229944,"['CAMK4', 'GABPA']",0.992453573650924,0,0,2
104,Interferon type I signaling pathways WP585,0.4527261154463574,1.3555758683729433,1.0742504132229944,"['RPS6', 'CRKL']",0.992453573650924,0,0,2
105,p38 MAPK Signaling Pathway WP400,0.4527261154463574,1.3555758683729433,1.0742504132229944,"['TRADD', 'DDIT3']",0.992453573650924,0,0,2
106,Rett syndrome causing genes WP4312,0.4527261154463574,1.3555758683729433,1.0742504132229944,"['GPS2', 'TBL1X']",0.992453573650924,0,0,2
107,Apoptosis WP254,0.4544636358896121,1.2324342324342323,0.9719437011428087,"['TRADD', 'BAX', 'FADD']",0.992453573650924,0,0,3
108,Head and Neck Squamous Cell Carcinoma WP4674,0.4544636358896121,1.2324342324342323,0.9719437011428087,"['RPS6', 'FADD', 'TGFBR2']",0.992453573650924,0,0,3
109,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.4734982639463284,1.6941149635036497,1.2665322610713805,['HTR2C'],0.992453573650924,0,0,1
110,Apoptosis Modulation by HSP70 WP384,0.4734982639463284,1.6941149635036497,1.2665322610713805,['FADD'],0.992453573650924,0,0,1
111,Computational Model of Aerobic Glycolysis WP4629,0.4734982639463284,1.6941149635036497,1.2665322610713805,['PFKM'],0.992453573650924,0,0,1
112,Fatty acid transporters WP5061,0.4734982639463284,1.6941149635036497,1.2665322610713805,['FABP6'],0.992453573650924,0,0,1
113,Nucleotide metabolism WP404,0.4734982639463284,1.6941149635036497,1.2665322610713805,['NME2'],0.992453573650924,0,0,1
114,Overview of nanoparticle effects WP3287,0.4734982639463284,1.6941149635036497,1.2665322610713805,['BAX'],0.992453573650924,0,0,1
115,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.4734982639463284,1.6941149635036497,1.2665322610713805,['BAX'],0.992453573650924,0,0,1
116,Modulators of TCR signaling and T cell activation WP5072,0.47606609766847263,1.2908505266823365,0.9580674198189177,"['NDUFB10', 'ELOB']",0.992453573650924,0,0,2
117,Selenium Micronutrient Network WP15,0.4906205688552552,1.1616954474097332,0.8272249990077698,"['SELENOM', 'SELENOK', 'SELENOH']",0.992453573650924,0,0,3
118,MET in type 1 papillary renal cell carcinoma WP4205,0.4987904033364253,1.2320093069636031,0.8569478572297786,"['RPL11', 'CRKL']",0.992453573650924,0,0,2
119,TNF-alpha signaling pathway WP231,0.5082534401932355,1.1292735042735043,0.7642641411196119,"['TRADD', 'BAX', 'FADD']",0.992453573650924,0,0,3
120,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5097426327291587,1.5056772100567721,1.0145995676682378,['SST'],0.992453573650924,0,0,1
121,Hypertrophy Model WP516,0.5097426327291587,1.5056772100567721,1.0145995676682378,['IL1R1'],0.992453573650924,0,0,1
122,Kallmann's Syndrome WP5074,0.5097426327291587,1.5056772100567721,1.0145995676682378,['CHD7'],0.992453573650924,0,0,1
123,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5097426327291587,1.5056772100567721,1.0145995676682378,['SCO2'],0.992453573650924,0,0,1
124,Calcium Regulation in the Cardiac Cell WP536,0.532064737513546,1.0421380090497738,0.6575787769532259,"['CHRM3', 'RGS16', 'CAMK4', 'CAMK2A', 'RYR3']",0.992453573650924,0,0,5
125,16p11.2 distal deletion syndrome WP4950,0.5434961651779701,1.35492700729927,0.8261432052286147,['RAB4A'],0.992453573650924,0,0,1
126,Striated Muscle Contraction Pathway WP383,0.5434961651779701,1.35492700729927,0.8261432052286147,['TPM2'],0.992453573650924,0,0,1
127,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5434961651779701,1.35492700729927,0.8261432052286147,['RPS6'],0.992453573650924,0,0,1
128,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5434961651779701,1.35492700729927,0.8261432052286147,['B3GALT2'],0.992453573650924,0,0,1
129,miRNA targets in ECM and membrane receptors WP2911,0.5434961651779701,1.35492700729927,0.8261432052286147,['THBS2'],0.992453573650924,0,0,1
130,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5434961651779701,1.35492700729927,0.8261432052286147,['GRB10'],0.992453573650924,0,0,1
131,PPAR-alpha pathway WP2878,0.5434961651779701,1.35492700729927,0.8261432052286147,['CPT1A'],0.992453573650924,0,0,1
132,Pregnane X receptor pathway WP2876,0.5434961651779701,1.35492700729927,0.8261432052286147,['PSMC5'],0.992453573650924,0,0,1
133,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5434961651779701,1.35492700729927,0.8261432052286147,['BAX'],0.992453573650924,0,0,1
134,Prader-Willi and Angelman Syndrome WP3998,0.5630428228904473,1.0837294332723948,0.622493744052817,"['SNURF', 'HTR2C']",0.992453573650924,0,0,2
135,Sphingolipid Metabolism (general overview) WP4725,0.574929748842439,1.2315859323158593,0.6816919538442753,['CERS6'],0.992453573650924,0,0,1
136,Sphingolipid Metabolism (integrated pathway) WP4726,0.574929748842439,1.2315859323158593,0.6816919538442753,['CERS6'],0.992453573650924,0,0,1
137,Ebstein-Barr virus LMP1 signaling WP262,0.574929748842439,1.2315859323158593,0.6816919538442753,['TRADD'],0.992453573650924,0,0,1
138,Fluoropyrimidine Activity WP1601,0.574929748842439,1.2315859323158593,0.6816919538442753,['TDG'],0.992453573650924,0,0,1
139,Heart Development WP1591,0.574929748842439,1.2315859323158593,0.6816919538442753,['VEGFB'],0.992453573650924,0,0,1
140,Methionine De Novo and Salvage Pathway WP3580,0.574929748842439,1.2315859323158593,0.6816919538442753,['MSRB3'],0.992453573650924,0,0,1
141,Neural Crest Cell Migration during Development WP4564,0.574929748842439,1.2315859323158593,0.6816919538442753,['CDH11'],0.992453573650924,0,0,1
142,B Cell Receptor Signaling Pathway WP23,0.5753839153152459,1.0157967032967032,0.5614489009858075,"['BCL6', 'CAMK2A', 'CRKL']",0.992453573650924,0,0,3
143,Synaptic Vesicle Pathway WP2267,0.5831072171226318,1.0419069047953875,0.5619881261408478,"['SLC32A1', 'PARK7']",0.992453573650924,0,0,2
144,16p11.2 proximal deletion syndrome WP4949,0.5912478412182127,0.9908871616188689,0.520731011660652,"['TMEM219', 'SEZ6L2', 'CCT7']",0.992453573650924,0,0,3
145,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6024841537659463,1.0031823413907508,0.508306387784011,"['APEX1', 'RPS6']",0.992453573650924,0,0,2
146,Cell migration and invasion through p75NTR WP4561,0.6042025673666955,1.128801703163017,0.5687419529659665,['CDH11'],0.992453573650924,0,0,1
147,Type II interferon signaling (IFNG) WP619,0.6042025673666955,1.128801703163017,0.5687419529659665,['HLA-B'],0.992453573650924,0,0,1
148,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6042025673666955,1.128801703163017,0.5687419529659665,['FADD'],0.992453573650924,0,0,1
149,Hematopoietic Stem Cell Differentiation WP2849,0.6042025673666955,1.128801703163017,0.5687419529659665,['KCNH2'],0.992453573650924,0,0,1
150,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6042025673666955,1.128801703163017,0.5687419529659665,['BAX'],0.992453573650924,0,0,1
151,Neural Crest Cell Migration in Cancer WP4565,0.6042025673666955,1.128801703163017,0.5687419529659665,['CDH11'],0.992453573650924,0,0,1
152,Genotoxicity pathway WP4286,0.6211731446490389,0.9672238182293027,0.46053919121374687,"['RPS27', 'TRIAP1']",0.992453573650924,0,0,2
153,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6211731446490389,0.9672238182293027,0.46053919121374687,"['IFI27L2', 'CAMK2A']",0.992453573650924,0,0,2
154,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6211731446490389,0.9672238182293027,0.46053919121374687,"['GRB14', 'BAX']",0.992453573650924,0,0,2
155,7-oxo-C and 7beta-HC pathways WP5064,0.6314629004257483,1.0418304323413812,0.4789462099375495,['EPHX2'],0.992453573650924,0,0,1
156,Endothelin Pathways WP2197,0.6314629004257483,1.0418304323413812,0.4789462099375495,['NPY1R'],0.992453573650924,0,0,1
157,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6314629004257483,1.0418304323413812,0.4789462099375495,['TGFBR2'],0.992453573650924,0,0,1
158,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6314629004257483,1.0418304323413812,0.4789462099375495,['TGFBR2'],0.992453573650924,0,0,1
159,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6314629004257483,1.0418304323413812,0.4789462099375495,['FERMT3'],0.992453573650924,0,0,1
160,Photodynamic therapy-induced unfolded protein response WP3613,0.6314629004257483,1.0418304323413812,0.4789462099375495,['DDIT3'],0.992453573650924,0,0,1
161,PKC-gamma calcium signaling pathway in ataxia WP4760,0.6314629004257483,1.0418304323413812,0.4789462099375495,['RYR3'],0.992453573650924,0,0,1
162,Acute viral myocarditis WP4298,0.6391770135528708,0.9337451932169198,0.4179199277340952,"['ENDOG', 'BAX']",0.992453573650924,0,0,2
163,Exercise-induced Circadian Regulation WP410,0.6391770135528708,0.9337451932169198,0.4179199277340952,"['UGP2', 'SUMO1']",0.992453573650924,0,0,2
164,Male infertility WP4673,0.6507712923174054,0.9023199023199023,0.38763393750032377,"['HLA-DRA', 'HORMAD1', 'LRWD1']",0.992453573650924,0,0,3
165,PPAR signaling pathway WP3942,0.6565014445678506,0.902498476538696,0.37979878119361565,"['CPT1A', 'FABP6']",0.992453573650924,0,0,2
166,Unfolded protein response WP4925,0.6568488696789593,0.9672836287799792,0.4065505839484335,['DDIT3'],0.992453573650924,0,0,1
167,Melatonin metabolism and effects WP3298,0.6568488696789593,0.9672836287799792,0.4065505839484335,['CAMK2A'],0.992453573650924,0,0,1
168,Monoamine Transport WP727,0.6568488696789593,0.9672836287799792,0.4065505839484335,['IL1R1'],0.992453573650924,0,0,1
169,DNA damage response WP707,0.6731545766444508,0.8732676770655187,0.3456221368624936,"['BAX', 'BRCA1']",0.992453573650924,0,0,2
170,Pathways affected in adenoid cystic carcinoma WP3651,0.6731545766444508,0.8732676770655187,0.3456221368624936,"['SETD2', 'BRCA1']",0.992453573650924,0,0,2
171,Sleep regulation WP3591,0.6804891332458234,0.902676399026764,0.3474793454276584,['CRH'],0.992453573650924,0,0,1
172,Sphingolipid pathway WP1422,0.6804891332458234,0.902676399026764,0.3474793454276584,['CERS6'],0.992453573650924,0,0,1
173,IL17 signaling pathway WP2112,0.6804891332458234,0.902676399026764,0.3474793454276584,['IL17RE'],0.992453573650924,0,0,1
174,SARS-CoV-2 mitochondrial interactions WP5038,0.6804891332458234,0.902676399026764,0.3474793454276584,['NDUFB9'],0.992453573650924,0,0,1
175,miRNA regulation of DNA damage response WP1530,0.6891466404844018,0.845863802559415,0.31491610849430846,"['BAX', 'BRCA1']",0.992453573650924,0,0,2
176,7q11.23 copy number variation syndrome WP4932,0.6911870392517994,0.8455815018315018,0.3123111414592943,"['ATP5PO', 'ATP5F1E', 'ATP5MC1']",0.992453573650924,0,0,3
177,Signal transduction through IL1R WP4496,0.7025035331065516,0.8461450729927007,0.2987779277689442,['IL1R1'],0.992453573650924,0,0,1
178,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7025035331065516,0.8461450729927007,0.2987779277689442,['CRKL'],0.992453573650924,0,0,1
179,Amyotrophic lateral sclerosis (ALS) WP2447,0.7025035331065516,0.8461450729927007,0.2987779277689442,['BAX'],0.992453573650924,0,0,1
180,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7025035331065516,0.8461450729927007,0.2987779277689442,['FADD'],0.992453573650924,0,0,1
181,Disruption of postsynaptic signaling by CNV WP4875,0.7025035331065516,0.8461450729927007,0.2987779277689442,['CAMK2A'],0.992453573650924,0,0,1
182,Fatty acid beta-oxidation WP143,0.7025035331065516,0.8461450729927007,0.2987779277689442,['CPT1A'],0.992453573650924,0,0,1
183,GABA receptor Signaling WP4159,0.7025035331065516,0.8461450729927007,0.2987779277689442,['SLC32A1'],0.992453573650924,0,0,1
184,Gastric Cancer Network 2 WP2363,0.7025035331065516,0.8461450729927007,0.2987779277689442,['SNURF'],0.992453573650924,0,0,1
185,IL-5 signaling pathway WP127,0.7025035331065516,0.8461450729927007,0.2987779277689442,['RPS6'],0.992453573650924,0,0,1
186,Interleukin-11 Signaling Pathway WP2332,0.7025035331065516,0.8461450729927007,0.2987779277689442,['RPS6'],0.992453573650924,0,0,1
187,Oxysterols derived from cholesterol WP4545,0.7025035331065516,0.8461450729927007,0.2987779277689442,['EPHX2'],0.992453573650924,0,0,1
188,Leptin signaling pathway WP2034,0.7044896331895608,0.8201207689324691,0.2872732667070362,"['RPS6', 'BAX']",0.992453573650924,0,0,2
189,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7230036980978344,0.7962644911979391,0.25826117507800916,['RPS6'],0.992453573650924,0,0,1
190,Glycogen Synthesis and Degradation WP500,0.7230036980978344,0.7962644911979391,0.25826117507800916,['UGP2'],0.992453573650924,0,0,1
191,Prostaglandin Synthesis and Regulation WP98,0.7230036980978344,0.7962644911979391,0.25826117507800916,['ANXA2'],0.992453573650924,0,0,1
192,Regulation of Microtubule Cytoskeleton WP2038,0.7230036980978344,0.7962644911979391,0.25826117507800916,['CAMK4'],0.992453573650924,0,0,1
193,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7332835158093597,0.7730477931574824,0.23981710009191268,"['BAX', 'TGFBR2']",0.992453573650924,0,0,2
194,DNA IR-damage and cellular response via ATR WP4016,0.7332835158093597,0.7730477931574824,0.23981710009191268,"['BCL6', 'BRCA1']",0.992453573650924,0,0,2
195,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.7332835158093597,0.7730477931574824,0.23981710009191268,"['PSMC5', 'PSMC1']",0.992453573650924,0,0,2
196,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7420936059690143,0.7519261962692619,0.2242844632424484,['CAMK4'],0.992453573650924,0,0,1
197,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7420936059690143,0.7519261962692619,0.2242844632424484,['DDIT3'],0.992453573650924,0,0,1
198,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.7420936059690143,0.7519261962692619,0.2242844632424484,['RAB4A'],0.992453573650924,0,0,1
199,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7420936059690143,0.7519261962692619,0.2242844632424484,['CAMK2A'],0.992453573650924,0,0,1
200,Peptide GPCRs WP24,0.7420936059690143,0.7519261962692619,0.2242844632424484,['NPY1R'],0.992453573650924,0,0,1
201,Aryl Hydrocarbon Receptor Pathway WP2873,0.7598701067481533,0.7122550902804456,0.19559078378115874,['BAX'],0.992453573650924,0,0,1
202,ATM Signaling Pathway WP2516,0.7598701067481533,0.7122550902804456,0.19559078378115874,['BRCA1'],0.992453573650924,0,0,1
203,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7598701067481533,0.7122550902804456,0.19559078378115874,['BRCA1'],0.992453573650924,0,0,1
204,Nuclear receptors WP170,0.7598701067481533,0.7122550902804456,0.19559078378115874,['NR2F2'],0.992453573650924,0,0,1
205,One-carbon metabolism and related pathways WP3940,0.7598701067481533,0.7122550902804456,0.19559078378115874,['CHKA'],0.992453573650924,0,0,1
206,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7598701067481533,0.7122550902804456,0.19559078378115874,['BAX'],0.992453573650924,0,0,1
207,Pre-implantation embryo WP3527,0.7598701067481533,0.7122550902804456,0.19559078378115874,['DDIT3'],0.992453573650924,0,0,1
208,Gastrin signaling pathway WP4659,0.7612567442789328,0.751017501017501,0.20486600899675567,"['KAT5', 'ANXA2', 'RPS6']",0.992453573650924,0,0,3
209,Fragile X Syndrome  WP4549,0.7715894167059428,0.7372627372627373,0.1911742287633906,"['CPT1A', 'CAMK4', 'CAMK2A']",0.992453573650924,0,0,3
210,IL-6 signaling pathway WP364,0.7764234105583402,0.6765510948905109,0.17120617676840846,['VIP'],0.992453573650924,0,0,1
211,NRF2 pathway WP2884,0.7815539022080052,0.7239992150706437,0.17844492546831786,"['SLC6A16', 'MAFF', 'TGFBR2']",0.992453573650924,0,0,3
212,Corticotropin-releasing hormone signaling pathway WP2355,0.7837446060983668,0.6933858341536586,0.16895876098287488,"['CAMK2A', 'CRH']",0.992453573650924,0,0,2
213,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7918375421718793,0.6442474800139034,0.15036673802894662,['IGFBP5'],0.992453573650924,0,0,1
214,Insulin Signaling WP481,0.7937936786299683,0.7300768658566824,0.16859789329173336,"['RAB4A', 'GRB14', 'GRB10', 'PFKM']",0.992453573650924,0,0,4
215,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7949747669651569,0.6759597806215722,0.1550955273091978,"['RPS6', 'BAX']",0.992453573650924,0,0,2
216,ErbB signaling pathway WP673,0.7949747669651569,0.6759597806215722,0.1550955273091978,"['CAMK2A', 'CRKL']",0.992453573650924,0,0,2
217,ATM Signaling Network in Development and Disease  WP3878,0.8061907641997456,0.6148805573988055,0.13246672176075777,['KAT5'],0.992453573650924,0,0,1
218,Glycolysis and Gluconeogenesis WP534,0.8061907641997456,0.6148805573988055,0.13246672176075777,['PFKM'],0.992453573650924,0,0,1
219,IL-3 signaling pathway WP286,0.8061907641997456,0.6148805573988055,0.13246672176075777,['CRKL'],0.992453573650924,0,0,1
220,Thermogenesis WP4321,0.8158978444573661,0.6435971097762688,0.13095020835972135,"['CPT1A', 'RPS6']",0.992453573650924,0,0,2
221,Pancreatic adenocarcinoma pathway WP4263,0.8158978444573661,0.6435971097762688,0.13095020835972135,"['BAX', 'TGFBR2']",0.992453573650924,0,0,2
222,Vitamin D Receptor Pathway WP2877,0.8178794273858326,0.6753663003663004,0.13577587911087177,"['IGFBP5', 'BCL6', 'ZNF257']",0.992453573650924,0,0,3
223,Regulation of Actin Cytoskeleton WP51,0.8178794273858326,0.6753663003663004,0.13577587911087177,"['CHRM3', 'TMSB4X', 'WASF1']",0.992453573650924,0,0,3
224,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.8195559716629243,0.5880672802284989,0.11702102728148542,['DDIT3'],0.992453573650924,0,0,1
225,Nucleotide Excision Repair WP4753,0.8195559716629243,0.5880672802284989,0.11702102728148542,['GTF2H5'],0.992453573650924,0,0,1
226,p53 transcriptional gene network WP4963,0.8195559716629243,0.5880672802284989,0.11702102728148542,['BAX'],0.992453573650924,0,0,1
227,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.8261176719757225,0.6642046478112051,0.1268750803378002,"['KCNH2', 'CPT1A', 'SST']",0.992453573650924,0,0,3
228,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8320010596665015,0.5634884428223844,0.1036376759951517,['BAX'],0.992453573650924,0,0,1
229,Metapathway biotransformation Phase I and II WP702,0.8340354051487392,0.6534030485643388,0.11857920974778578,"['CYP2C8', 'EPHX2', 'CYP20A1']",0.992453573650924,0,0,3
230,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.8435892654504865,0.5408759124087591,0.09199734333279255,['TMSB4X'],0.992453573650924,0,0,1
231,TGF-beta Receptor Signaling WP560,0.8435892654504865,0.5408759124087591,0.09199734333279255,['TGFBR2'],0.992453573650924,0,0,1
232,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8435892654504865,0.5408759124087591,0.09199734333279255,['RPS6'],0.992453573650924,0,0,1
233,"GPCRs, Other WP117",0.8435892654504865,0.5408759124087591,0.09199734333279255,['CHRM3'],0.992453573650924,0,0,1
234,IL-1 signaling pathway WP195,0.8435892654504865,0.5408759124087591,0.09199734333279255,['IL1R1'],0.992453573650924,0,0,1
235,Hepatitis B infection WP4666,0.8489439136044101,0.6328125,0.10363073970283099,"['BAX', 'FADD', 'TGFBR2']",0.992453573650924,0,0,3
236,Wnt signaling WP428,0.8520977480315122,0.5873142039583499,0.09400200580534464,"['CAMK2A', 'NKD1']",0.992453573650924,0,0,2
237,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8559521444664657,0.6229923922231615,0.09690074155962014,"['CAMK4', 'RPS6', 'CAMK2A']",0.992453573650924,0,0,3
238,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8644265829018557,0.5006758583400919,0.072942915965477,['TGFBR2'],0.992453573650924,0,0,1
239,Complement system WP2806,0.8644265829018557,0.5006758583400919,0.072942915965477,['RPS19'],0.992453573650924,0,0,1
240,Proximal tubule transport WP4917,0.8644265829018557,0.5006758583400919,0.072942915965477,['SLC7A9'],0.992453573650924,0,0,1
241,Regulation of toll-like receptor signaling pathway WP1449,0.8676557382173891,0.5626904326630103,0.07987967896752815,"['CYLD', 'FADD']",0.992453573650924,0,0,2
242,Ebola Virus Pathway on Host WP4217,0.8748585238480029,0.5511323359325448,0.07368258649330259,"['HLA-B', 'HLA-DRA']",0.992453573650924,0,0,2
243,DNA damage response (only ATM dependent) WP710,0.8816987810884289,0.540036563071298,0.06799319511312632,"['BCL6', 'BAX']",0.992453573650924,0,0,2
244,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8906027387828022,0.4504257907542579,0.05218489565867048,['IL1R1'],0.992453573650924,0,0,1
245,Nuclear Receptors Meta-Pathway WP2882,0.8952012717984869,0.6461878453038674,0.07153732477310397,"['CPT1A', 'PSMC5', 'SLC6A16', 'MAFF', 'BAX', 'TGFBR2']",0.992453573650924,0,0,6
246,AMP-activated protein kinase (AMPK) signaling WP1403,0.8981543679608671,0.4358370614551448,0.04681470727210641,['CPT1A'],0.992453573650924,0,0,1
247,Translation Factors WP107,0.8981543679608671,0.4358370614551448,0.04681470727210641,['EEF1B2'],0.992453573650924,0,0,1
248,Endometrial cancer WP4155,0.8981543679608671,0.4358370614551448,0.04681470727210641,['BAX'],0.992453573650924,0,0,1
249,Joubert Syndrome WP4656,0.905185586061947,0.4221601277372263,0.04205360305870253,['KAT5'],0.992453573650924,0,0,1
250,Oncostatin M Signaling Pathway WP2374,0.905185586061947,0.4221601277372263,0.04205360305870253,['RPS6'],0.992453573650924,0,0,1
251,Spinal Cord Injury WP2431,0.9057416312119473,0.499763017130476,0.04947713285022809,"['IL1R1', 'APEX1']",0.992453573650924,0,0,2
252,TGF-beta Signaling Pathway WP366,0.9057416312119473,0.499763017130476,0.04947713285022809,"['SUMO1', 'TGFBR2']",0.992453573650924,0,0,2
253,Melanoma WP4685,0.9117321955817644,0.409312099093121,0.03782411244318988,['BAX'],0.992453573650924,0,0,1
254,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9117321955817644,0.409312099093121,0.03782411244318988,['NKD1'],0.992453573650924,0,0,1
255,Prolactin Signaling Pathway WP2037,0.9117321955817644,0.409312099093121,0.03782411244318988,['RPS6'],0.992453573650924,0,0,1
256,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9178275399729509,0.3972198368398454,0.03405992115190366,['SLC38A2'],0.992453573650924,0,0,1
257,Endochondral Ossification WP474,0.9178275399729509,0.3972198368398454,0.03405992115190366,['SLC38A2'],0.992453573650924,0,0,1
258,MAPK Signaling Pathway WP382,0.9195098486386828,0.590250902992776,0.049530623643095156,"['DUSP4', 'IL1R1', 'DDIT3', 'CRKL', 'TGFBR2']",0.992453573650924,0,0,5
259,Circadian rhythm related genes WP3594,0.9202189888687144,0.5250463821892394,0.04365424947208068,"['CPT1A', 'CRH', 'RPS27A']",0.992453573650924,0,0,3
260,Mesodermal commitment pathway WP2857,0.9206908735095611,0.4732672632220405,0.03910651944348668,"['SETD2', 'RPL38']",0.992453573650924,0,0,2
261,Toll-like Receptor Signaling Pathway WP75,0.9235026725892079,0.3858185610010427,0.030704052749041467,['FADD'],0.992453573650924,0,0,1
262,Wnt signaling pathway and pluripotency WP399,0.9235026725892079,0.3858185610010427,0.030704052749041467,['NKD1'],0.992453573650924,0,0,1
263,Non-small cell lung cancer WP4255,0.9235026725892079,0.3858185610010427,0.030704052749041467,['BAX'],0.992453573650924,0,0,1
264,Ectoderm Differentiation WP2858,0.9251575265133599,0.46504444304356046,0.03617639180176372,"['NR2F2', 'TBL1X']",0.992453573650924,0,0,2
265,T-cell receptor (TCR) signaling pathway WP69,0.9287865132647664,0.3750506893755069,0.027707383236768718,['CRKL'],0.992453573650924,0,0,1
266,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9337059952399545,0.36486486486486486,0.02502742034092144,['NKD1'],0.992453573650924,0,0,1
267,Retinoblastoma gene in cancer WP2446,0.9337059952399545,0.36486486486486486,0.02502742034092144,['H2AFZ'],0.992453573650924,0,0,1
268,Glioblastoma signaling pathways WP2261,0.9382862007903439,0.35521513638109875,0.0226272959756372,['BRCA1'],0.992453573650924,0,0,1
269,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9465206116844509,0.3373631386861314,0.018542332248246522,['RPS6'],0.992453573650924,0,0,1
270,Genes related to primary cilium development (based on CRISPR) WP4536,0.9465206116844509,0.3373631386861314,0.018542332248246522,['TTC30B'],0.992453573650924,0,0,1
271,Adipogenesis WP236,0.9473497443752041,0.421103747714808,0.02277621134051213,"['EPAS1', 'DDIT3']",0.992453573650924,0,0,2
272,Breast cancer pathway WP4262,0.9532389592857113,0.4082322309013351,0.01955010375654798,"['BAX', 'BRCA1']",0.992453573650924,0,0,2
273,Pathways Regulating Hippo Signaling WP4540,0.9568617045361588,0.31369886267187236,0.013832992829931704,['CDH11'],0.992453573650924,0,0,1
274,Senescence and Autophagy in Cancer WP615,0.9598442925059799,0.3065278699402787,0.01256280044115208,['IGFBP5'],0.992453573650924,0,0,1
275,Focal Adhesion WP306,0.9654671266293094,0.4337705305447241,0.015244095665990196,"['VEGFB', 'THBS2', 'CRKL']",0.992453573650924,0,0,3
276,Hippo-Merlin Signaling Dysregulation WP4541,0.9676125561588468,0.2868457835067557,0.009443973960063528,['CDH11'],0.992453573650924,0,0,1
277,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9698695296706126,0.4932823313148789,0.015091342524386145,"['PIK3IP1', 'EPAS1', 'RPS6', 'VEGFB', 'THBS2']",0.992453573650924,0,0,5
278,Small cell lung cancer WP4658,0.9803945697256706,0.24942552041092186,0.004938666753425852,['BAX'],0.992453573650924,0,0,1
279,Cell cycle WP179,0.9803945697256706,0.24942552041092186,0.004938666753425852,['ANAPC11'],0.992453573650924,0,0,1
280,Chemokine signaling pathway WP3929,0.9803945697256706,0.24942552041092186,0.004938666753425852,['CRKL'],0.992453573650924,0,0,1
281,Endoderm differentiation WP2853,0.9852863180401016,0.23209791089856532,0.0034403877592590823,['DUSP4'],0.992453573650924,0,0,1
282,Ciliopathies WP4803,0.9869892528153056,0.3088108596524407,0.0040442266527181145,"['XPNPEP3', 'AK7']",0.992453573650924,0,0,2
283,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.988959018814125,0.21700612196844832,0.0024092855591861515,['TGFBR2'],0.992453573650924,0,0,1
284,PI3K-Akt signaling pathway WP4172,0.9928854574388082,0.37161060142711516,0.0026532891410279993,"['RPS6', 'VEGFB', 'BRCA1', 'THBS2']",0.9928854574388082,0,0,4
